David Chatenet

Institut National de la Recherche Scientifique — Canada

Medicine · Health Sciences

27h-index2.1kcitations111works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiovascular, Neuropeptides, and Oxidative Stress Research(47), Apelin-related biomedical research(37), Hormonal Regulation and Hypertension(33), Neuropeptides and Animal Physiology(31), Receptor Mechanisms and Signaling(18)

Publications111 total

Network‐based allosteric analysis of galectin‐7: Key residues dictate functional communication and stability
Protein Science·2026Open Access
Structure-activity relationships of contulakin-G: Design, synthesis, and characterization of Thr10 analogs for pain modulation
Biomedicine & Pharmacotherapy·2025· 1 citedOpen Access
Immunomodulation With Local, Sustained Delivery of Pituitary Adenylate Cyclase Activating Polypeptide Results in Improved Functional Recovery in Stroke‐Injured Mice
Advanced Healthcare Materials·2025· 3 citedOpen Access
Development and Use of a Galectin-1-Specific Nanobody for Tumor Imaging and Elucidating the Role of Galectin-1 in Cancer
ACS Pharmacology & Translational Science·2025· 1 citedOpen Access
Development of Galectin-7-Specific Nanobodies: Implications for Immunotherapy and Molecular Imaging in Cancer
Journal of Medicinal Chemistry·2025· 1 citedOpen Access
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
Cellular Signalling·2025· 9 cited
Enhanced Gαq Signaling in <i>TSC2</i> -Deficient Cells Is Required for Their Neoplastic Behavior
American Journal of Respiratory Cell and Molecular Biology·2024· 2 cited
Expanding Structure–Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators
Journal of Medicinal Chemistry·2024
Evidence for heterodimerization and functional interaction of the urotensin II and the angiotensin II type 1 receptors
Cellular Signalling·2024· 1 cited
Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics
Journal of Medicinal Chemistry·2023· 6 cited
G Protein-Biased Agonists for Intracellular Angiotensin Receptors Promote Collagen Secretion in Myofibroblasts
ACS Chemical Biology·2023· 3 cited
Exploration of the urocontrin A scaffold yields new urotensinergic system allosteric modulator and competitive antagonists
Biochemical Pharmacology·2023· 2 cited
Placental Galectins in Cancer: Why We Should Pay More Attention
Cells·2023· 16 citedOpen Access
Tunable Surface Charge Enables the Electrostatic Adsorption-Controlled Release of Neuroprotective Peptides from a Hydrogel–Nanoparticle Drug Delivery System
ACS Applied Materials & Interfaces·2022· 31 cited
The complicated lives of GPCRs in cardiac fibroblasts
American Journal of Physiology-Cell Physiology·2022· 11 cited
Quantifying Biomolecular Interactions Using Slow Mixing Mode (SLOMO) Nanoflow ESI-MS
ACS Central Science·2022· 26 citedOpen Access
EVIDENCE FOR HETERODIMERIZATION AND FUNCTIONAL INTERACTION OF THE UROTENSIN II AND THE ANGIOTENSIN II TYPE 1 RECEPTORS
2022
List of contributors
Elsevier eBooks·2022
Exploring the use of intracellular and extracellular allosteric modulators to understand GPCR signaling
Elsevier eBooks·2022· 6 cited
Perturbing dimer interactions and allosteric communication modulates the immunosuppressive activity of human galectin-7
Journal of Biological Chemistry·2021· 9 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Alain Fournier(24), Myriam Létourneau(18), Jérôme Leprince(16), Hubert Vaudry(12), David Vaudry(8), Nicolas Doucet(8), Hubert Vaudry(7), Christophe Dubessy(6), Elizabeth Scalbert(6), Terence E. Hébert(6), Isabelle Lihrmann(5), Nicolas Chartrel(5), Artavazd Tadevosyan(5), Bruce G. Allen(5), Stanley Nattel(5), Étienne Billard(5), Benjamin Folch(5), Hervé Tostivint(4), Marie‐Christine Tonon(4), Louis Villeneuve(4)